Supplementary Figure 3 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy

Dun Niu; Shaotong Zhang; Xiaozhuang Ma; Yaran Wu; Junshi Zhu; Jingzhi Ran; Meihua Shan; Xufang Dai; Lu Lu; Mingzhen Yang; Jiqin Lian

doi:10.1158/1535-7163.31248794

Supplementary Figure 3 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy

2026 Open access

Read full text

Authors: Dun Niu, Shaotong Zhang, Xiaozhuang Ma, Yaran Wu, Junshi Zhu, Jingzhi Ran, Meihua Shan, Xufang Dai, Lu Lu, Mingzhen Yang, Jiqin Lian

DOI: 10.1158/1535-7163.31248794

Cited by: 0

Abstract

Comparison of the CDUPRT distribution, anti-tumor capacity and toxicity of mCDUPRT versus circCDUPRT after intravenous or intratumoral administration.

Fields of Study & Subjects

Circular RNAs in diseases Cancer Research and Treatments RNA Interference and Gene Delivery

Publication details

Publication date: 4 February 2026